跳至主要内容
临床试验/NCT07157163
NCT07157163尚未招募不适用

Effectiveness of Nudge and Motivational Interviewing Interventions to Improve Influenza Vaccination Uptake Among Healthcare Workers in China: a Two-phase Randomized Controlled Trial

Centers for Disease Control and Prevention, China0 个研究点目标入组 4,050 人开始时间: 2025年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
4,050
主要终点
Influenza vaccination uptake

研究概览

简要总结

The goal of this clinical trial is to learn if nudge-based interventions and motivational interviewing work to improve influenza vaccination uptake among healthcare workers in China. A two-phase randomized controlled trial will be conducted in community hospitals across China, targeting healthcare workers as participants.

The main questions are:

Do nudge-based interventions increase vaccination rates among healthcare workers?

Does motivational interviewing increase vaccination compliance among those who remain unvaccinated after the phase 1?

In phase 1, community hospitals will be randomized as units into three arms: standard nudge group, personalized nudge group, and a control group. In phase 2, healthcare workers who remain unvaccinated after phase 1 will be individually randomized to either a motivational interviewing group or a control group.

Participants will:

Be recruited from community hospitals to participate in the study. In phase 1 (at the early stage of the flu season), community hospitals will be randomly assigned to one of three groups: standardized nudge messages, personalized nudge messages with a chatbot, or no reminders.

If still unvaccinated in phase 2 (during peak flu season), healthcare workers will be individually assigned to either motivational interviewing group or receive no extra contact.

Have their vaccination status checked at the end of each phase.

详细描述

A two-phase randomized controlled trial will be conducted to evaluate the effectiveness of multi-component interventions to improve vaccination uptake, targeting healthcare workers in China.

Sample size Phase 1: Cluster-Randomized Controlled Trial The sample size is determined to identify a significant difference in the primary outcome, defined as the influenza vaccination uptake among healthcare workers in community hospital, comparing the intervention and control groups. Historical surveillance data from the three participating cities indicate a baseline vaccination rate of approximately 4% without targeted interventions. The proposed intervention is expected to increase this rate to 10%. A two-sided significance level of α = 0.05 is set, adjusted to α = 0.0167 via Bonferroni correction to account for three planned pairwise comparisons. Statistical power is set at 0.80, with an assumed intraclass correlation coefficient (ICC) of 0.05 and an average cluster size of 50 participants per cluster. Based on these parameters, 23 clusters per study arm are required, resulting in a total of 69 clusters across the three arms. To account for potential attrition, the sample size will be increased to 27 clusters per arm, yielding a total of 81 clusters and an estimated 4,050 participants. All eligible healthcare workers in the participating community hospitals will be included in the study.

Phase 2: Individual Randomized Controlled Trial In phase 2, the target population comprises healthcare workers who remain unvaccinated after Phase 1, from the 54 community hospitals assigned to the intervention arms. Without further intervention, the vaccination uptake rate in this group is estimated to be approximately 3%. The motivational interviewing intervention is expected to increase this rate to 13%. Assuming a two-sided significance level of α = 0.05 and statistical power of 0.80, sample size estimation indicates a minimum of 112 participants per group is required. To ensure feasibility and maintain study power, the motivational interviewing group will aim to enroll 150 participants. Fifteen community hospitals will be randomly selected from the two intervention arms of Phase 1. Control groups are established: 1) healthcare workers from 15 community hospitals selected for the motivational interviewing intervention, excluding approximately 10 individuals per community hospital who receive the intervention, resulting in a control group of approximately 525 healthcare workers; and 2) healthcare workers from the remaining 39 community hospitals not participating in the motivational interviewing intervention, comprising approximately 1,755 individuals. Therefore, the control group in phase 2 comprises approximately 2,280 participants.

In phase 1, a stratified block randomization method will be employed to ensure balanced allocation across study groups. Stratification factors include historical influenza vaccination rates among healthcare workers and the size of the healthcare staff at each community hospital. Community hospitals with comparable levels of these factors are grouped into blocks within each city and then randomly assigned within each block to one of three groups: the standardized nudge group, personalized nudge group, or a control group.

In phase 2, a two-stage random sampling procedure will be used. Specifically, 15 community hospitals will be randomly selected from the 54 hospitals assigned to the intervention groups in the phase 1 (five hospitals per province). Within each selected hospital, 10 healthcare workers who remained unvaccinated after the first-phase intervention will be randomly sampled and enrolled in the individual-level intervention study.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

盲法说明

Data analysts

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Phase 1: Cluster-Randomized Controlled Trial
  • •Inclusion Criteria:
  • •Full-time employees of community hospitals who remain employed throughout the study period.
  • •Have not scheduled or received an influenza vaccine between August 2024 and the time of formal enrollment.
  • •Agree to participate and provide informed consent.

排除标准

  • •Participants with medical conditions that contraindicate influenza vaccination.
  • •Participants who refuse to participate or do not provide informed consent .
  • •Phase 2: Individual Randomized Controlled Trial
  • •Inclusion Criteria:
  • •Healthcare workers from community hospitals who remain unvaccinated after Phase 1, as verified by official records, will be screened.
  • •A selected subset of these individuals will be invited to participate in Phase
  • •Exclusion Criteria:
  • •- Participants who refuse to participate or do not provide informed consent .

研究组 & 干预措施

Phase 1: standardized nudge group

Experimental

Participants receive uniform nudge messages.

干预措施: Phase 1: standardized nudge messages (Behavioral)

Phase 1: personalized nudge group

Experimental

Participants receive tailored nudge messages with access to a chatbot.

干预措施: Phase 1: personalized nudge messages + chatbot (Behavioral)

Phase 1: control group

No Intervention

Participants receive no study-related interventions.

Phase 2: motivational interviewing group

Experimental

Participants receive motivational interviewing.

干预措施: Phase 2: motivational Interviewing (Behavioral)

Phase 2: control group

No Intervention

Participants receive no study-related interventions.

结局指标

主要结局

Influenza vaccination uptake

时间窗: 2 months post-intervention for each study phase.

whether participants get vaccinated against influenza, measured by official vaccination system

次要结局

  • Access to professional information of influenza vaccine(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Influenza vaccine literacy(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • High perception on influenza risk(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Influenza vaccination intention(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Recommendation of influenza vaccine to the public.(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Influenza vaccine literacy(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Influenza vaccine confidence(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • High perception on influenza risk(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Influenza vaccination intention(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Access to professional information of influenza vaccine(Baseline (pre-intervention) and 2 weeks after each intervention phase.)
  • Recommendation of influenza vaccine to the public.(Baseline (pre-intervention) and 2 weeks after each intervention phase.)

研究者

发起方
Centers for Disease Control and Prevention, China
申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Lixin Hao

Chief Physician of National Immunization Program

Centers for Disease Control and Prevention, China

相似试验